Editas Medicine (EDIT) Cash from Financing Activities (2015 - 2025)
Editas Medicine (EDIT) reported Cash from Financing Activities of $17.2 million for Q3 2025, up 131.64% on a QoQ basis from $7.4 million in Q2 2025.
Editas Medicine (EDIT) has 11 years of Cash from Financing Activities data on file, last reported at $17.2 million in Q3 2025.
- Quarterly Cash from Financing Activities changed N/A year-over-year to $17.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $78.7 million (up 7551.46% YoY) and the FY2024 annual result came in at $56.0 million, down 52.54% from the prior year.
- Cash from Financing Activities climbed to $17.2 million in Q3 2025 per EDIT's latest filing, from $7.4 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $261.5 million in Q1 2021 and bottomed at -$1.4 million in Q1 2025.
- The 5-year median for Cash from Financing Activities is $838000.0 (2021), against an average of $30.0 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities soared 31923.16%; it then sank 848.44% in 2025.
- Tracing EDIT's Cash from Financing Activities over 5 years: stood at $1.1 million in 2021, then plunged by 41.44% to $619000.0 in 2022, then declined by 16.96% to $514000.0 in 2023, then surged by 10700.19% to $55.5 million in 2024, then tumbled by 69.07% to $17.2 million in 2025.
- Per Business Quant, the three latest EDIT Cash from Financing Activities figures stand at $17.2 million (Q3 2025), $7.4 million (Q2 2025), and -$1.4 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.17 Mn |
| Sep 30, 2025 | 17.17 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Jun 30, 2025 | 7.41 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | 55.51 Mn |
| Dec 31, 2024 | 55.51 Mn |
| Jun 30, 2024 | 322,000.00 |
| Jun 30, 2024 | 322,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Mar 31, 2024 | 192,000.00 |
| Dec 31, 2023 | 514,000.00 |
| Dec 31, 2023 | 514,000.00 |
| Jun 30, 2023 | 117.53 Mn |
| Jun 30, 2023 | 117.53 Mn |
| Dec 31, 2022 | 619,000.00 |
| Dec 31, 2022 | 619,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Sep 30, 2022 | 80,000.00 |
| Jun 30, 2022 | 367,000.00 |
| Jun 30, 2022 | 367,000.00 |
| Mar 31, 2022 | 218,000.00 |
| Mar 31, 2022 | 218,000.00 |
| Dec 31, 2021 | 1.06 Mn |
| Dec 31, 2021 | 1.06 Mn |
| Sep 30, 2021 | 2.50 Mn |
| Sep 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 17.08 Mn |
| Jun 30, 2021 | 17.08 Mn |
| Mar 31, 2021 | 261.47 Mn |
| Mar 31, 2021 | 261.47 Mn |
| Dec 31, 2020 | 9.10 Mn |
| Dec 31, 2020 | 9.10 Mn |
| Sep 30, 2020 | 822,000.00 |
| Sep 30, 2020 | 822,000.00 |
| Jun 30, 2020 | 211.15 Mn |
| Jun 30, 2020 | 211.15 Mn |
| Mar 31, 2020 | 3.05 Mn |
| Mar 31, 2020 | 3.05 Mn |
| Dec 31, 2019 | 84.57 Mn |
| Dec 31, 2019 | 84.57 Mn |
| Sep 30, 2019 | 43.35 Mn |
| Sep 30, 2019 | 43.35 Mn |
| Jun 30, 2019 | 2.37 Mn |
| Jun 30, 2019 | 2.37 Mn |
| Mar 31, 2019 | 1.53 Mn |
| Mar 31, 2019 | 1.53 Mn |
| Dec 31, 2018 | 30.35 Mn |
| Dec 31, 2018 | 30.35 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Sep 30, 2018 | 1.24 Mn |
| Jun 30, 2018 | 2.67 Mn |
| Jun 30, 2018 | 2.67 Mn |
| Mar 31, 2018 | 52.68 Mn |
| Mar 31, 2018 | 52.68 Mn |
| Sep 30, 2017 | 96.06 Mn |
| Sep 30, 2017 | 96.06 Mn |
| Jun 30, 2017 | 96.79 Mn |
| Jun 30, 2017 | 96.79 Mn |
| Mar 31, 2017 | 97.09 Mn |
| Mar 31, 2017 | 97.09 Mn |
| Dec 31, 2016 | -538,000.00 |
| Dec 31, 2016 | -538,000.00 |
| Sep 30, 2016 | -22,000.00 |
| Sep 30, 2016 | -22,000.00 |
| Jun 30, 2016 | -494,000.00 |
| Jun 30, 2016 | -494,000.00 |
| Mar 31, 2016 | 98.22 Mn |
| Mar 31, 2016 | 98.22 Mn |
| Dec 31, 2015 | -3.75 Mn |
| Dec 31, 2015 | -3.75 Mn |
| Sep 30, 2015 | 120.39 Mn |
| Sep 30, 2015 | 120.39 Mn |
| Jun 30, 2015 | 21.96 Mn |
| Jun 30, 2015 | 21.96 Mn |
| Mar 31, 2015 | 791,000.00 |
| Mar 31, 2015 | 791,000.00 |